tiprankstipranks
Trending News
More News >
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
US Market

Adverum Biotechnologies (ADVM) Income Statement

Compare
623 Followers

Adverum Biotechnologies Income Statement

Last quarter (Q1 2025), Adverum Biotechnologies's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Adverum Biotechnologies's net income was $-47.02M. See Adverum Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.00M$ 3.60M$ 0.00$ 7.50M$ 0.00
Gross Profit
$ -2.65M$ -2.04M$ -6.53M$ 2.85M$ -4.16M
Operating Expenses
$ 140.16M$ 127.59M$ 157.13M$ 153.62M$ 117.95M
Depreciation and Amortization
$ 3.65M$ 5.64M$ 6.53M$ 4.64M$ 4.16M
EBITDA
$ -127.27M$ -123.30M$ -147.93M$ -140.90M$ -112.23M
Operating Income
$ -139.16M$ -128.94M$ -157.13M$ -146.12M$ -117.95M
Other Income/Expenses
$ 8.23M$ 5.75M$ 549.00K$ -481.00K$ 1.56M
Pretax Income
$ -130.93M$ -123.19M$ -154.46M$ -145.54M$ -116.39M
Net Income
$ -130.93M$ -117.17M$ -154.54M$ -145.54M$ -117.51M
Per Share Metrics
Basic EPS
$ -6.62$ -12.11$ -15.57$ -14.85$ -13.80
Diluted EPS
$ -6.62$ -12.11$ -15.57$ -14.85$ -13.80
Weighted Average Shares Outstanding
19.78M 10.08M 9.93M 9.80M 8.51M
Weighted Average Shares Outstanding (Diluted)
19.78M 10.08M 9.93M 9.80M 8.51M
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis